Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Celiac Disease | 115 | 2024 | 785 | 21.060 |
Why?
|
Glutens | 49 | 2022 | 230 | 10.410 |
Why?
|
Haptoglobins | 40 | 2024 | 165 | 8.040 |
Why?
|
Diet, Gluten-Free | 39 | 2022 | 271 | 6.830 |
Why?
|
Intestinal Mucosa | 61 | 2023 | 3037 | 6.260 |
Why?
|
Protein Precursors | 38 | 2024 | 1154 | 6.070 |
Why?
|
Cholera Toxin | 35 | 2020 | 556 | 5.080 |
Why?
|
Tight Junctions | 29 | 2023 | 311 | 4.280 |
Why?
|
Gliadin | 29 | 2023 | 79 | 4.020 |
Why?
|
Permeability | 39 | 2022 | 738 | 3.740 |
Why?
|
Duodenum | 14 | 2022 | 484 | 2.980 |
Why?
|
Transglutaminases | 19 | 2023 | 194 | 2.900 |
Why?
|
Oligopeptides | 12 | 2021 | 1189 | 2.260 |
Why?
|
Intestine, Small | 16 | 2019 | 1240 | 2.050 |
Why?
|
Autoimmune Diseases | 18 | 2021 | 2134 | 1.970 |
Why?
|
Intestines | 18 | 2021 | 1924 | 1.600 |
Why?
|
Intestinal Absorption | 11 | 2019 | 420 | 1.550 |
Why?
|
Gastrointestinal Tract | 12 | 2022 | 814 | 1.550 |
Why?
|
Immunoglobulin A | 18 | 2023 | 995 | 1.370 |
Why?
|
Gastrointestinal Diseases | 8 | 2021 | 1170 | 1.360 |
Why?
|
Autoimmunity | 10 | 2021 | 1350 | 1.310 |
Why?
|
Food Hypersensitivity | 7 | 2020 | 622 | 1.290 |
Why?
|
Probiotics | 7 | 2022 | 351 | 1.280 |
Why?
|
Irritable Bowel Syndrome | 7 | 2020 | 445 | 1.170 |
Why?
|
Salmonella typhi | 6 | 2024 | 201 | 1.120 |
Why?
|
Systemic Inflammatory Response Syndrome | 8 | 2023 | 612 | 1.100 |
Why?
|
Autoantibodies | 18 | 2023 | 2036 | 1.070 |
Why?
|
Intestinal Diseases | 5 | 2021 | 530 | 1.000 |
Why?
|
Colostrum | 1 | 2023 | 28 | 0.930 |
Why?
|
Blood-Brain Barrier | 6 | 2022 | 1019 | 0.890 |
Why?
|
Inflammation | 21 | 2023 | 10637 | 0.880 |
Why?
|
Factor X | 1 | 2022 | 64 | 0.880 |
Why?
|
Diabetes Mellitus, Type 1 | 6 | 2023 | 3338 | 0.840 |
Why?
|
Humans | 239 | 2024 | 744366 | 0.840 |
Why?
|
Typhoid Fever | 5 | 2024 | 197 | 0.830 |
Why?
|
Serologic Tests | 8 | 2019 | 374 | 0.830 |
Why?
|
Enterocolitis, Necrotizing | 2 | 2016 | 341 | 0.830 |
Why?
|
Shigella flexneri | 4 | 2019 | 132 | 0.820 |
Why?
|
GTP-Binding Proteins | 4 | 2017 | 970 | 0.820 |
Why?
|
Diet | 9 | 2020 | 7937 | 0.770 |
Why?
|
Gastrointestinal Transit | 1 | 2021 | 96 | 0.770 |
Why?
|
HLA Antigens | 6 | 2019 | 1382 | 0.740 |
Why?
|
Gastric Emptying | 2 | 2021 | 233 | 0.740 |
Why?
|
HLA-DQ Antigens | 9 | 2020 | 210 | 0.730 |
Why?
|
Cytokines | 18 | 2023 | 7323 | 0.700 |
Why?
|
Addison Disease | 1 | 2020 | 48 | 0.700 |
Why?
|
Child | 68 | 2024 | 77709 | 0.700 |
Why?
|
Inflammatory Bowel Diseases | 5 | 2020 | 2428 | 0.700 |
Why?
|
Metagenome | 2 | 2013 | 418 | 0.680 |
Why?
|
Dermatitis Herpetiformis | 5 | 2014 | 26 | 0.670 |
Why?
|
Metabolome | 7 | 2023 | 895 | 0.670 |
Why?
|
Intercellular Junctions | 1 | 2019 | 203 | 0.660 |
Why?
|
Receptors, CXCR3 | 2 | 2010 | 237 | 0.640 |
Why?
|
Caco-2 Cells | 12 | 2022 | 387 | 0.630 |
Why?
|
Cell Membrane Permeability | 4 | 2011 | 590 | 0.630 |
Why?
|
Wheat Hypersensitivity | 3 | 2018 | 9 | 0.620 |
Why?
|
Biopsy | 15 | 2022 | 6755 | 0.590 |
Why?
|
Breast Feeding | 5 | 2019 | 1338 | 0.580 |
Why?
|
Interleukin-8 | 5 | 2019 | 690 | 0.580 |
Why?
|
Hypersensitivity | 3 | 2016 | 1102 | 0.570 |
Why?
|
Peptides | 5 | 2021 | 4410 | 0.570 |
Why?
|
Vomiting | 1 | 2020 | 637 | 0.560 |
Why?
|
Antibodies, Anti-Idiotypic | 3 | 2020 | 349 | 0.550 |
Why?
|
Metabolomics | 7 | 2022 | 1485 | 0.540 |
Why?
|
Infant | 35 | 2024 | 35134 | 0.530 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2015 | 162 | 0.520 |
Why?
|
Diarrhea | 11 | 2020 | 1348 | 0.510 |
Why?
|
Animals | 68 | 2023 | 168768 | 0.510 |
Why?
|
Receptors, Formyl Peptide | 1 | 2015 | 145 | 0.510 |
Why?
|
Chickens | 1 | 2016 | 865 | 0.500 |
Why?
|
Antibodies | 9 | 2019 | 2460 | 0.490 |
Why?
|
Schizophrenia | 11 | 2020 | 6882 | 0.490 |
Why?
|
Gastrointestinal Agents | 1 | 2019 | 494 | 0.490 |
Why?
|
Shigella dysenteriae | 1 | 2014 | 14 | 0.490 |
Why?
|
Lactobacillus | 2 | 2019 | 189 | 0.480 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2016 | 232 | 0.470 |
Why?
|
DNA, Bacterial | 1 | 2019 | 1465 | 0.470 |
Why?
|
Epithelial Cells | 11 | 2021 | 3690 | 0.470 |
Why?
|
Interleukin-10 | 2 | 2020 | 1200 | 0.470 |
Why?
|
Automation, Laboratory | 1 | 2014 | 101 | 0.460 |
Why?
|
Receptor, PAR-2 | 2 | 2010 | 32 | 0.460 |
Why?
|
Immunoglobulin G | 16 | 2023 | 4561 | 0.460 |
Why?
|
Antiviral Agents | 4 | 2023 | 2987 | 0.450 |
Why?
|
Genetic Predisposition to Disease | 14 | 2021 | 17446 | 0.450 |
Why?
|
Food Contamination | 2 | 2013 | 188 | 0.450 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2016 | 341 | 0.450 |
Why?
|
Bacteria | 6 | 2020 | 2115 | 0.440 |
Why?
|
Feeding Methods | 2 | 2017 | 35 | 0.440 |
Why?
|
Abdominal Pain | 2 | 2018 | 1064 | 0.430 |
Why?
|
Child, Preschool | 34 | 2024 | 41005 | 0.420 |
Why?
|
Malabsorption Syndromes | 3 | 2018 | 135 | 0.420 |
Why?
|
Antibodies, Viral | 9 | 2024 | 3177 | 0.420 |
Why?
|
Hospitals, General | 1 | 2016 | 749 | 0.420 |
Why?
|
Enterobacteriaceae | 3 | 2021 | 169 | 0.410 |
Why?
|
Food | 3 | 2020 | 772 | 0.410 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2017 | 868 | 0.400 |
Why?
|
Immunity, Mucosal | 5 | 2020 | 490 | 0.400 |
Why?
|
Down-Regulation | 2 | 2017 | 3001 | 0.400 |
Why?
|
Colitis | 2 | 2017 | 1170 | 0.390 |
Why?
|
Hypersensitivity, Delayed | 1 | 2012 | 484 | 0.380 |
Why?
|
Peptide Hydrolases | 3 | 2018 | 634 | 0.380 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2012 | 0.380 |
Why?
|
Female | 91 | 2024 | 380193 | 0.380 |
Why?
|
Hedgehog Proteins | 1 | 2015 | 783 | 0.380 |
Why?
|
Male | 86 | 2024 | 350115 | 0.370 |
Why?
|
Milk, Human | 3 | 2021 | 490 | 0.370 |
Why?
|
Infant Nutritional Physiological Phenomena | 2 | 2017 | 347 | 0.370 |
Why?
|
Immunity | 6 | 2024 | 1014 | 0.370 |
Why?
|
Autistic Disorder | 2 | 2017 | 1185 | 0.360 |
Why?
|
Immunoassay | 1 | 2014 | 752 | 0.360 |
Why?
|
Case-Control Studies | 18 | 2022 | 21748 | 0.360 |
Why?
|
Allergens | 2 | 2015 | 1320 | 0.360 |
Why?
|
Critical Illness | 2 | 2022 | 2670 | 0.360 |
Why?
|
Metagenomics | 4 | 2021 | 428 | 0.360 |
Why?
|
Child Development | 5 | 2018 | 2223 | 0.350 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1739 | 0.350 |
Why?
|
Infant, Newborn | 23 | 2022 | 25628 | 0.350 |
Why?
|
Immunity, Innate | 6 | 2019 | 2962 | 0.350 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2022 | 2026 | 0.350 |
Why?
|
Helicobacter pylori | 1 | 2013 | 383 | 0.350 |
Why?
|
Stomach | 2 | 2018 | 697 | 0.350 |
Why?
|
Obesity | 4 | 2023 | 12746 | 0.340 |
Why?
|
Cerebellum | 1 | 2016 | 1488 | 0.340 |
Why?
|
Adolescent | 35 | 2023 | 85779 | 0.340 |
Why?
|
Forkhead Transcription Factors | 1 | 2017 | 1613 | 0.340 |
Why?
|
Thyroid Nodule | 1 | 2016 | 750 | 0.340 |
Why?
|
Myosins | 1 | 2010 | 409 | 0.330 |
Why?
|
RNA, Ribosomal, 16S | 5 | 2023 | 954 | 0.330 |
Why?
|
Host-Pathogen Interactions | 2 | 2016 | 1480 | 0.320 |
Why?
|
Neutrophils | 3 | 2022 | 3721 | 0.320 |
Why?
|
Diagnosis, Differential | 9 | 2020 | 12961 | 0.320 |
Why?
|
Interferon-gamma | 1 | 2017 | 3207 | 0.320 |
Why?
|
Interleukin-17 | 3 | 2019 | 901 | 0.320 |
Why?
|
Triticum | 4 | 2018 | 86 | 0.310 |
Why?
|
Child Development Disorders, Pervasive | 4 | 2013 | 615 | 0.310 |
Why?
|
Culture Media, Conditioned | 1 | 2009 | 537 | 0.310 |
Why?
|
Antibody Formation | 2 | 2022 | 1402 | 0.310 |
Why?
|
Mice, Transgenic | 7 | 2023 | 9735 | 0.300 |
Why?
|
Sepsis | 1 | 2021 | 2593 | 0.300 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2725 | 0.290 |
Why?
|
Fatty Liver | 1 | 2013 | 727 | 0.290 |
Why?
|
Pituitary Gland | 1 | 2010 | 665 | 0.290 |
Why?
|
Young Adult | 24 | 2023 | 56429 | 0.290 |
Why?
|
Endothelial Cells | 3 | 2016 | 3486 | 0.290 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8642 | 0.280 |
Why?
|
Mice, Inbred C57BL | 16 | 2023 | 21833 | 0.280 |
Why?
|
Consensus Development Conferences, NIH as Topic | 1 | 2005 | 28 | 0.280 |
Why?
|
Environment | 3 | 2020 | 1123 | 0.270 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2019 | 2200 | 0.270 |
Why?
|
Feces | 7 | 2022 | 1401 | 0.270 |
Why?
|
Phosphoproteins | 4 | 2020 | 2441 | 0.270 |
Why?
|
Patient Compliance | 3 | 2013 | 2684 | 0.270 |
Why?
|
Specimen Handling | 2 | 2020 | 694 | 0.270 |
Why?
|
Myocarditis | 2 | 2023 | 771 | 0.260 |
Why?
|
Lipopolysaccharides | 6 | 2021 | 2216 | 0.260 |
Why?
|
Bacterial Translocation | 3 | 2020 | 73 | 0.260 |
Why?
|
Mice | 30 | 2023 | 81201 | 0.260 |
Why?
|
Psychotic Disorders | 5 | 2019 | 3046 | 0.260 |
Why?
|
Feeding Behavior | 2 | 2015 | 3188 | 0.250 |
Why?
|
Escherichia coli | 4 | 2019 | 4217 | 0.250 |
Why?
|
Endotoxins | 11 | 2010 | 527 | 0.250 |
Why?
|
Adult | 44 | 2024 | 214052 | 0.250 |
Why?
|
Wound Healing | 1 | 2015 | 2785 | 0.250 |
Why?
|
Dysentery, Bacillary | 2 | 2016 | 75 | 0.240 |
Why?
|
Cell Movement | 2 | 2019 | 5218 | 0.240 |
Why?
|
Adaptive Immunity | 3 | 2021 | 714 | 0.240 |
Why?
|
Leukocytes, Mononuclear | 4 | 2018 | 1837 | 0.240 |
Why?
|
Organoids | 2 | 2021 | 701 | 0.240 |
Why?
|
Genetic Testing | 3 | 2014 | 3444 | 0.240 |
Why?
|
Shigella Vaccines | 2 | 2014 | 7 | 0.240 |
Why?
|
Viral Load | 3 | 2021 | 3300 | 0.230 |
Why?
|
Epigenesis, Genetic | 1 | 2017 | 3646 | 0.230 |
Why?
|
Biological Warfare | 1 | 2003 | 24 | 0.230 |
Why?
|
Body Height | 1 | 2010 | 1578 | 0.230 |
Why?
|
Anti-Bacterial Agents | 6 | 2024 | 7182 | 0.230 |
Why?
|
Toll-Like Receptor 4 | 5 | 2020 | 565 | 0.230 |
Why?
|
Claudins | 3 | 2016 | 111 | 0.220 |
Why?
|
Organ Culture Techniques | 5 | 2019 | 813 | 0.220 |
Why?
|
Synbiotics | 1 | 2022 | 9 | 0.220 |
Why?
|
Budesonide | 2 | 2022 | 154 | 0.220 |
Why?
|
Helminths | 1 | 2023 | 35 | 0.220 |
Why?
|
Receptor, Cannabinoid, CB2 | 2 | 2013 | 49 | 0.220 |
Why?
|
Risk Factors | 17 | 2020 | 72296 | 0.220 |
Why?
|
Predictive Value of Tests | 7 | 2020 | 15078 | 0.220 |
Why?
|
Mass Screening | 3 | 2009 | 5253 | 0.210 |
Why?
|
Bacteroides | 2 | 2020 | 161 | 0.210 |
Why?
|
Prospective Studies | 20 | 2023 | 53290 | 0.210 |
Why?
|
Helminthiasis | 1 | 2023 | 66 | 0.210 |
Why?
|
Haplotypes | 5 | 2020 | 2779 | 0.210 |
Why?
|
Bioterrorism | 1 | 2003 | 143 | 0.210 |
Why?
|
Prevalence | 11 | 2019 | 15221 | 0.210 |
Why?
|
Terminology as Topic | 3 | 2015 | 1547 | 0.200 |
Why?
|
Bifidobacterium | 2 | 2019 | 100 | 0.200 |
Why?
|
Osteoporosis | 2 | 2012 | 1579 | 0.200 |
Why?
|
Typhoid-Paratyphoid Vaccines | 2 | 2018 | 39 | 0.200 |
Why?
|
Bacterial Toxins | 2 | 2005 | 931 | 0.200 |
Why?
|
Anorexia Nervosa | 2 | 2021 | 1286 | 0.200 |
Why?
|
Vero Cells | 1 | 2022 | 485 | 0.200 |
Why?
|
Amino Acid Sequence | 6 | 2015 | 13814 | 0.200 |
Why?
|
Comorbidity | 8 | 2020 | 10388 | 0.200 |
Why?
|
Gastric Mucosa | 2 | 2021 | 599 | 0.190 |
Why?
|
Interleukin-1beta | 5 | 2019 | 972 | 0.190 |
Why?
|
Viral Nonstructural Proteins | 1 | 2022 | 241 | 0.190 |
Why?
|
Blood Cells | 1 | 2023 | 309 | 0.190 |
Why?
|
Glomerulonephritis, IGA | 1 | 2021 | 67 | 0.190 |
Why?
|
Cell Line | 8 | 2021 | 16000 | 0.190 |
Why?
|
Radiation Injuries, Experimental | 2 | 2016 | 91 | 0.190 |
Why?
|
Complementarity Determining Regions | 1 | 2021 | 149 | 0.190 |
Why?
|
Viral Matrix Proteins | 1 | 2021 | 186 | 0.190 |
Why?
|
Pilot Projects | 8 | 2021 | 8319 | 0.190 |
Why?
|
Gene Expression Regulation | 5 | 2020 | 12073 | 0.190 |
Why?
|
Membrane Proteins | 7 | 2017 | 7882 | 0.180 |
Why?
|
Kynurenic Acid | 1 | 2020 | 46 | 0.180 |
Why?
|
Pregnancy | 12 | 2023 | 29144 | 0.180 |
Why?
|
Herpesvirus 3, Human | 1 | 2021 | 204 | 0.180 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5709 | 0.180 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2020 | 118 | 0.180 |
Why?
|
Longitudinal Studies | 7 | 2021 | 13991 | 0.180 |
Why?
|
Salmonella paratyphi B | 1 | 2019 | 3 | 0.180 |
Why?
|
Immunologic Tests | 1 | 2020 | 103 | 0.180 |
Why?
|
Gastroenterology | 4 | 2016 | 538 | 0.180 |
Why?
|
Molecular Sequence Data | 5 | 2015 | 18111 | 0.180 |
Why?
|
Diarrhea, Infantile | 2 | 2019 | 109 | 0.180 |
Why?
|
Cell Differentiation | 6 | 2023 | 11486 | 0.180 |
Why?
|
Monocytes | 6 | 2022 | 2596 | 0.180 |
Why?
|
Periodontal Diseases | 1 | 2023 | 449 | 0.180 |
Why?
|
Salmonella paratyphi A | 1 | 2019 | 47 | 0.170 |
Why?
|
Chromosome Disorders | 1 | 2022 | 514 | 0.170 |
Why?
|
Bacterial Adhesion | 2 | 2019 | 316 | 0.170 |
Why?
|
Hematologic Tests | 1 | 2020 | 240 | 0.170 |
Why?
|
Treatment Failure | 2 | 2017 | 2618 | 0.170 |
Why?
|
Pancrelipase | 1 | 2018 | 7 | 0.170 |
Why?
|
Enterobacteriaceae Infections | 1 | 2021 | 187 | 0.170 |
Why?
|
Drug Repositioning | 1 | 2021 | 230 | 0.170 |
Why?
|
Growth Disorders | 1 | 2004 | 645 | 0.170 |
Why?
|
Stem Cells | 4 | 2019 | 3567 | 0.170 |
Why?
|
Flagellin | 1 | 2019 | 125 | 0.170 |
Why?
|
Lactococcus lactis | 1 | 2018 | 28 | 0.170 |
Why?
|
Catalytic Domain | 1 | 2021 | 698 | 0.170 |
Why?
|
Dextran Sulfate | 2 | 2017 | 236 | 0.170 |
Why?
|
Molecular Dynamics Simulation | 1 | 2021 | 409 | 0.160 |
Why?
|
Protease Inhibitors | 1 | 2022 | 791 | 0.160 |
Why?
|
Serine Endopeptidases | 3 | 2020 | 1073 | 0.160 |
Why?
|
Signal Transduction | 11 | 2020 | 23404 | 0.160 |
Why?
|
Cattle | 2 | 2023 | 3922 | 0.160 |
Why?
|
Salmonella Infections | 1 | 2019 | 173 | 0.160 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2018 | 48 | 0.160 |
Why?
|
Gastroparesis | 1 | 2020 | 131 | 0.160 |
Why?
|
Weightlessness | 2 | 2016 | 87 | 0.160 |
Why?
|
Tryptophan | 1 | 2020 | 478 | 0.160 |
Why?
|
Iron Overload | 1 | 2020 | 242 | 0.160 |
Why?
|
Rats | 14 | 2017 | 24252 | 0.150 |
Why?
|
Disease Management | 2 | 2020 | 2460 | 0.150 |
Why?
|
Bone Marrow | 2 | 2020 | 2948 | 0.150 |
Why?
|
Placenta | 3 | 2022 | 1699 | 0.150 |
Why?
|
Middle Aged | 28 | 2021 | 213390 | 0.150 |
Why?
|
Genomics | 4 | 2023 | 5717 | 0.150 |
Why?
|
Bioreactors | 2 | 2016 | 236 | 0.150 |
Why?
|
Pharmaceutical Preparations | 1 | 2006 | 1070 | 0.150 |
Why?
|
Dairy Products | 1 | 2021 | 498 | 0.150 |
Why?
|
Environmental Exposure | 1 | 2012 | 4232 | 0.150 |
Why?
|
Massachusetts | 3 | 2020 | 8662 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2021 | 805 | 0.150 |
Why?
|
Liver | 1 | 2013 | 7475 | 0.150 |
Why?
|
Severity of Illness Index | 8 | 2021 | 15535 | 0.150 |
Why?
|
Nephrotic Syndrome | 1 | 2021 | 389 | 0.150 |
Why?
|
Duodenoscopy | 1 | 2017 | 52 | 0.150 |
Why?
|
RNA, Messenger | 9 | 2024 | 13035 | 0.150 |
Why?
|
Diagnostic Techniques, Digestive System | 2 | 2018 | 47 | 0.150 |
Why?
|
Incidence | 6 | 2022 | 20952 | 0.150 |
Why?
|
Gene Expression Regulation, Bacterial | 3 | 2019 | 1122 | 0.150 |
Why?
|
Microvilli | 3 | 2013 | 241 | 0.150 |
Why?
|
Ileitis | 1 | 2017 | 44 | 0.150 |
Why?
|
Antigens, Viral | 1 | 2021 | 1035 | 0.150 |
Why?
|
Double-Blind Method | 6 | 2022 | 12025 | 0.150 |
Why?
|
HMGA1a Protein | 1 | 2017 | 64 | 0.150 |
Why?
|
Cross-Sectional Studies | 8 | 2023 | 25039 | 0.140 |
Why?
|
Cytomegalovirus | 1 | 2021 | 733 | 0.140 |
Why?
|
Vaccines, Attenuated | 2 | 2018 | 342 | 0.140 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2021 | 1320 | 0.140 |
Why?
|
Capsule Endoscopy | 1 | 2018 | 125 | 0.140 |
Why?
|
Paneth Cells | 1 | 2017 | 99 | 0.140 |
Why?
|
Stress, Psychological | 2 | 2023 | 4245 | 0.140 |
Why?
|
Peptide Fragments | 6 | 2015 | 5096 | 0.140 |
Why?
|
Major Histocompatibility Complex | 1 | 2019 | 936 | 0.140 |
Why?
|
Immunologic Factors | 3 | 2018 | 1580 | 0.140 |
Why?
|
Polysaccharides, Bacterial | 1 | 2018 | 578 | 0.130 |
Why?
|
Age Factors | 5 | 2020 | 18373 | 0.130 |
Why?
|
Models, Immunological | 1 | 2018 | 527 | 0.130 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2017 | 310 | 0.130 |
Why?
|
N-Formylmethionine Leucyl-Phenylalanine | 1 | 2015 | 222 | 0.130 |
Why?
|
Disease Models, Animal | 9 | 2021 | 18034 | 0.130 |
Why?
|
Up-Regulation | 4 | 2017 | 4222 | 0.130 |
Why?
|
Endoscopy, Digestive System | 2 | 2018 | 345 | 0.130 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2020 | 1475 | 0.130 |
Why?
|
Whole-Body Irradiation | 1 | 2016 | 449 | 0.130 |
Why?
|
Spondylitis, Ankylosing | 1 | 2017 | 156 | 0.130 |
Why?
|
Phenotype | 6 | 2023 | 16367 | 0.130 |
Why?
|
Prenatal Diagnosis | 1 | 2022 | 1236 | 0.130 |
Why?
|
Practice Guidelines as Topic | 5 | 2012 | 7282 | 0.130 |
Why?
|
Models, Biological | 4 | 2014 | 9584 | 0.130 |
Why?
|
Sensitivity and Specificity | 6 | 2018 | 14723 | 0.130 |
Why?
|
Chemotactic Factors | 1 | 2015 | 199 | 0.130 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2021 | 1366 | 0.120 |
Why?
|
Anemia | 2 | 2015 | 1503 | 0.120 |
Why?
|
Cells, Cultured | 10 | 2019 | 19233 | 0.120 |
Why?
|
Th17 Cells | 2 | 2021 | 766 | 0.120 |
Why?
|
Drug Delivery Systems | 1 | 2006 | 2219 | 0.120 |
Why?
|
Duodenal Diseases | 1 | 2015 | 102 | 0.120 |
Why?
|
Fetal Blood | 1 | 2020 | 1318 | 0.120 |
Why?
|
Lymphocytosis | 1 | 2015 | 119 | 0.120 |
Why?
|
Cohort Studies | 8 | 2023 | 40559 | 0.120 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2017 | 407 | 0.120 |
Why?
|
Endothelium | 1 | 2017 | 778 | 0.120 |
Why?
|
Macrophages | 3 | 2023 | 5660 | 0.120 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1031 | 0.120 |
Why?
|
Body Weight | 3 | 2017 | 4671 | 0.120 |
Why?
|
Receptors, Steroid | 1 | 2014 | 155 | 0.120 |
Why?
|
Gene Expression | 4 | 2019 | 7798 | 0.120 |
Why?
|
Pediatrics | 3 | 2019 | 3475 | 0.110 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 1678 | 0.110 |
Why?
|
Behavior, Animal | 1 | 2021 | 1881 | 0.110 |
Why?
|
Enterocytes | 2 | 2021 | 225 | 0.110 |
Why?
|
Electric Impedance | 3 | 2013 | 729 | 0.110 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2016 | 638 | 0.110 |
Why?
|
Histocompatibility Testing | 2 | 2007 | 741 | 0.110 |
Why?
|
Colony Count, Microbial | 1 | 2014 | 331 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2020 | 3873 | 0.110 |
Why?
|
Neutrophil Infiltration | 1 | 2015 | 391 | 0.110 |
Why?
|
Asia | 1 | 2014 | 609 | 0.110 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2013 | 143 | 0.110 |
Why?
|
Ileum | 4 | 2017 | 565 | 0.110 |
Why?
|
Delayed Diagnosis | 1 | 2016 | 441 | 0.110 |
Why?
|
Drug Discovery | 1 | 2021 | 1058 | 0.110 |
Why?
|
Radiation Protection | 1 | 2016 | 419 | 0.110 |
Why?
|
Switzerland | 3 | 2018 | 256 | 0.110 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2015 | 675 | 0.110 |
Why?
|
Binding Sites | 1 | 2021 | 6111 | 0.110 |
Why?
|
Sex Distribution | 2 | 2016 | 2297 | 0.110 |
Why?
|
Aged | 15 | 2021 | 163288 | 0.110 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3135 | 0.110 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3242 | 0.100 |
Why?
|
Jejunum | 2 | 2012 | 480 | 0.100 |
Why?
|
Dendritic Cells | 3 | 2020 | 2725 | 0.100 |
Why?
|
Cell Communication | 1 | 2019 | 1621 | 0.100 |
Why?
|
Protein Isoforms | 1 | 2017 | 1730 | 0.100 |
Why?
|
Longevity | 1 | 2019 | 1071 | 0.100 |
Why?
|
Infant Food | 1 | 2012 | 141 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2020 | 10943 | 0.100 |
Why?
|
Calcium-Binding Proteins | 1 | 2016 | 1081 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2016 | 3922 | 0.100 |
Why?
|
Immune Tolerance | 2 | 2016 | 2259 | 0.100 |
Why?
|
Brain | 2 | 2017 | 26388 | 0.100 |
Why?
|
Antigens, Plant | 1 | 2011 | 86 | 0.100 |
Why?
|
T-Lymphocytes | 3 | 2023 | 10183 | 0.100 |
Why?
|
Postmenopause | 1 | 2020 | 2460 | 0.100 |
Why?
|
Carrier Proteins | 2 | 2022 | 5023 | 0.100 |
Why?
|
Lymphocytes | 4 | 2019 | 2617 | 0.100 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2166 | 0.100 |
Why?
|
Microfilament Proteins | 1 | 2016 | 1152 | 0.100 |
Why?
|
Leukocytes | 1 | 2019 | 2045 | 0.100 |
Why?
|
Patient Participation | 1 | 2020 | 1457 | 0.100 |
Why?
|
Enterotoxins | 1 | 2012 | 368 | 0.100 |
Why?
|
Treatment Outcome | 7 | 2021 | 63107 | 0.100 |
Why?
|
Endometrial Neoplasms | 1 | 2020 | 1351 | 0.100 |
Why?
|
Reproducibility of Results | 4 | 2020 | 19905 | 0.100 |
Why?
|
Weight Loss | 2 | 2020 | 2625 | 0.100 |
Why?
|
Vaccination | 5 | 2024 | 3279 | 0.090 |
Why?
|
Primary Health Care | 1 | 2007 | 4557 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1790 | 0.090 |
Why?
|
Bioengineering | 1 | 2011 | 99 | 0.090 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2015 | 838 | 0.090 |
Why?
|
Protein Kinase C-alpha | 1 | 2010 | 112 | 0.090 |
Why?
|
Pandemics | 5 | 2021 | 8385 | 0.090 |
Why?
|
Atrophy | 2 | 2013 | 1584 | 0.090 |
Why?
|
Regeneration | 2 | 2016 | 1485 | 0.090 |
Why?
|
Weight Gain | 1 | 2020 | 2293 | 0.090 |
Why?
|
Metabolic Diseases | 1 | 2016 | 658 | 0.090 |
Why?
|
Cholestasis | 1 | 2013 | 378 | 0.090 |
Why?
|
Immune System Diseases | 1 | 2012 | 261 | 0.090 |
Why?
|
Hordeum | 1 | 2009 | 20 | 0.090 |
Why?
|
Threonine | 1 | 2010 | 279 | 0.090 |
Why?
|
Public Health | 1 | 2003 | 2602 | 0.090 |
Why?
|
Complement System Proteins | 1 | 2013 | 795 | 0.090 |
Why?
|
Age of Onset | 3 | 2021 | 3270 | 0.090 |
Why?
|
Cross-Over Studies | 1 | 2015 | 2029 | 0.090 |
Why?
|
Receptors, CCR6 | 1 | 2009 | 81 | 0.090 |
Why?
|
Lactation | 2 | 2022 | 412 | 0.090 |
Why?
|
Musculoskeletal Diseases | 1 | 2015 | 581 | 0.090 |
Why?
|
Myeloid Differentiation Factor 88 | 3 | 2008 | 571 | 0.090 |
Why?
|
Dietary Proteins | 1 | 2014 | 963 | 0.090 |
Why?
|
Phylogeny | 2 | 2018 | 2804 | 0.080 |
Why?
|
Acute Lung Injury | 1 | 2013 | 380 | 0.080 |
Why?
|
Interleukin-15 | 1 | 2010 | 184 | 0.080 |
Why?
|
Sweden | 1 | 2012 | 1341 | 0.080 |
Why?
|
Sulfonamides | 1 | 2018 | 1940 | 0.080 |
Why?
|
Immunoblotting | 2 | 2010 | 1683 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6539 | 0.080 |
Why?
|
Caspases | 1 | 2012 | 928 | 0.080 |
Why?
|
Italy | 3 | 2019 | 832 | 0.080 |
Why?
|
Alleles | 1 | 2020 | 6933 | 0.080 |
Why?
|
Principal Component Analysis | 1 | 2012 | 940 | 0.080 |
Why?
|
Bone Diseases, Metabolic | 1 | 2012 | 417 | 0.080 |
Why?
|
Acute Disease | 4 | 2023 | 7147 | 0.080 |
Why?
|
Rats, Wistar | 2 | 2010 | 1892 | 0.080 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2009 | 361 | 0.080 |
Why?
|
Retrospective Studies | 7 | 2022 | 77460 | 0.080 |
Why?
|
Nutritional Support | 1 | 2020 | 168 | 0.080 |
Why?
|
Time Factors | 5 | 2022 | 40075 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2015 | 1677 | 0.080 |
Why?
|
Mental Health | 1 | 2022 | 3010 | 0.080 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2020 | 370 | 0.080 |
Why?
|
Cell Proliferation | 4 | 2019 | 10483 | 0.080 |
Why?
|
Genome-Wide Association Study | 2 | 2019 | 12262 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2009 | 343 | 0.080 |
Why?
|
Receptors, Proteinase-Activated | 1 | 2007 | 19 | 0.080 |
Why?
|
Drug Administration Routes | 1 | 2007 | 153 | 0.080 |
Why?
|
Antigens | 1 | 2013 | 1466 | 0.080 |
Why?
|
Europe | 1 | 2014 | 3338 | 0.080 |
Why?
|
Genetic Loci | 2 | 2014 | 2575 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2213 | 0.080 |
Why?
|
Eosinophilic Esophagitis | 1 | 2020 | 168 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2021 | 2988 | 0.070 |
Why?
|
Chronic Disease | 2 | 2019 | 9145 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39052 | 0.070 |
Why?
|
Interleukin-23 | 1 | 2008 | 194 | 0.070 |
Why?
|
Adjuvants, Immunologic | 2 | 2003 | 1000 | 0.070 |
Why?
|
Mice, Inbred BALB C | 4 | 2010 | 6386 | 0.070 |
Why?
|
Bacterial Proteins | 2 | 2019 | 3854 | 0.070 |
Why?
|
Cell Survival | 3 | 2014 | 5882 | 0.070 |
Why?
|
Age Distribution | 2 | 2010 | 2902 | 0.070 |
Why?
|
Skin Diseases | 1 | 2015 | 1066 | 0.070 |
Why?
|
Serine | 1 | 2010 | 826 | 0.070 |
Why?
|
Algorithms | 4 | 2014 | 13882 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3086 | 0.070 |
Why?
|
Aged, 80 and over | 6 | 2018 | 57776 | 0.070 |
Why?
|
Bacteremia | 1 | 2013 | 963 | 0.070 |
Why?
|
ROC Curve | 1 | 2014 | 3528 | 0.070 |
Why?
|
Tomography, Optical Coherence | 1 | 2018 | 2657 | 0.070 |
Why?
|
United States | 7 | 2022 | 69872 | 0.070 |
Why?
|
Inflammation Mediators | 3 | 2021 | 1888 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2021 | 3712 | 0.070 |
Why?
|
RNA Interference | 2 | 2014 | 2890 | 0.070 |
Why?
|
Societies, Medical | 4 | 2013 | 3743 | 0.070 |
Why?
|
Prognosis | 3 | 2020 | 29060 | 0.070 |
Why?
|
Rats, Inbred BB | 1 | 2005 | 31 | 0.070 |
Why?
|
Feasibility Studies | 3 | 2021 | 5077 | 0.070 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 2 | 2021 | 546 | 0.070 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2009 | 1572 | 0.070 |
Why?
|
Adherens Junctions | 2 | 2017 | 90 | 0.070 |
Why?
|
Constipation | 2 | 2022 | 546 | 0.060 |
Why?
|
Lactoferrin | 1 | 2005 | 97 | 0.060 |
Why?
|
Fibroblasts | 2 | 2016 | 4162 | 0.060 |
Why?
|
Antibodies, Bacterial | 2 | 2018 | 1470 | 0.060 |
Why?
|
Child Nutritional Physiological Phenomena | 2 | 2004 | 303 | 0.060 |
Why?
|
Physicians, Family | 1 | 2007 | 345 | 0.060 |
Why?
|
Th1 Cells | 1 | 2010 | 1057 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2015 | 1622 | 0.060 |
Why?
|
Biological Availability | 4 | 2007 | 397 | 0.060 |
Why?
|
Interleukin-1 | 1 | 2008 | 1263 | 0.060 |
Why?
|
Cyclosporine | 1 | 2007 | 788 | 0.060 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 1865 | 0.060 |
Why?
|
Lymphocyte Count | 1 | 2007 | 793 | 0.060 |
Why?
|
Anorexia | 1 | 2005 | 161 | 0.060 |
Why?
|
Early Diagnosis | 1 | 2009 | 1184 | 0.060 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2006 | 339 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2022 | 2307 | 0.060 |
Why?
|
Nose | 1 | 2007 | 509 | 0.060 |
Why?
|
Fluid Therapy | 2 | 2005 | 593 | 0.060 |
Why?
|
Mental Disorders | 2 | 2015 | 6598 | 0.060 |
Why?
|
Acyclovir | 1 | 2004 | 272 | 0.060 |
Why?
|
RNA, Viral | 2 | 2023 | 2901 | 0.060 |
Why?
|
North America | 1 | 2007 | 1249 | 0.060 |
Why?
|
Microscopy, Fluorescence | 2 | 2012 | 2700 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2017 | 9955 | 0.060 |
Why?
|
Referral and Consultation | 1 | 2016 | 3531 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2012 | 1343 | 0.060 |
Why?
|
Gastroesophageal Reflux | 1 | 2020 | 782 | 0.050 |
Why?
|
Tetanus Toxoid | 1 | 2003 | 193 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2012 | 2566 | 0.050 |
Why?
|
Anthrax | 1 | 2003 | 88 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 7 | 2007 | 8300 | 0.050 |
Why?
|
Gallbladder | 1 | 2024 | 302 | 0.050 |
Why?
|
Fatty Acids, Volatile | 1 | 2023 | 102 | 0.050 |
Why?
|
Mannitol | 1 | 2003 | 181 | 0.050 |
Why?
|
Finland | 1 | 2003 | 602 | 0.050 |
Why?
|
Salmonella | 1 | 2022 | 129 | 0.050 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2002 | 121 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2009 | 6621 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 3759 | 0.050 |
Why?
|
Gangliosides | 1 | 2002 | 137 | 0.050 |
Why?
|
Macromolecular Substances | 1 | 2004 | 1454 | 0.050 |
Why?
|
Escherichia coli Infections | 1 | 2005 | 532 | 0.050 |
Why?
|
Mucus | 1 | 2023 | 321 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2019 | 4424 | 0.050 |
Why?
|
Digestive System | 1 | 2002 | 253 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2013 | 3280 | 0.050 |
Why?
|
Protein Biosynthesis | 1 | 2008 | 2126 | 0.050 |
Why?
|
Drug Carriers | 1 | 2005 | 693 | 0.050 |
Why?
|
Staphylococcus aureus | 1 | 2009 | 1453 | 0.050 |
Why?
|
Bone Development | 1 | 2004 | 483 | 0.050 |
Why?
|
Analysis of Variance | 3 | 2017 | 6366 | 0.050 |
Why?
|
Thioctic Acid | 1 | 2020 | 23 | 0.050 |
Why?
|
Polymerase Chain Reaction | 2 | 2012 | 6171 | 0.050 |
Why?
|
Neutrophil Activation | 1 | 2021 | 186 | 0.050 |
Why?
|
Methane | 1 | 2020 | 51 | 0.050 |
Why?
|
Genotype | 3 | 2014 | 12952 | 0.050 |
Why?
|
Clinical Competence | 1 | 2016 | 4687 | 0.050 |
Why?
|
Bariatric Surgery | 1 | 2020 | 952 | 0.050 |
Why?
|
Bangladesh | 1 | 2022 | 687 | 0.050 |
Why?
|
Blotting, Western | 3 | 2012 | 5181 | 0.050 |
Why?
|
Asymptomatic Infections | 1 | 2021 | 128 | 0.050 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2003 | 555 | 0.040 |
Why?
|
Arginase | 1 | 2020 | 79 | 0.040 |
Why?
|
Transfection | 1 | 2008 | 5895 | 0.040 |
Why?
|
Mucins | 1 | 2023 | 564 | 0.040 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2012 | 2408 | 0.040 |
Why?
|
Immobilization | 1 | 2020 | 236 | 0.040 |
Why?
|
Cadherins | 2 | 2017 | 907 | 0.040 |
Why?
|
Endoscopy | 1 | 2009 | 1787 | 0.040 |
Why?
|
Immunity, Humoral | 1 | 2024 | 598 | 0.040 |
Why?
|
Colitis, Ulcerative | 1 | 2011 | 1911 | 0.040 |
Why?
|
Immunoglobulin M | 2 | 2020 | 1537 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9647 | 0.040 |
Why?
|
Phosphorylation | 1 | 2010 | 8436 | 0.040 |
Why?
|
Administration, Intranasal | 3 | 2007 | 446 | 0.040 |
Why?
|
Logistic Models | 3 | 2016 | 13409 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2022 | 541 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2018 | 3508 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2008 | 2917 | 0.040 |
Why?
|
HT29 Cells | 1 | 2019 | 200 | 0.040 |
Why?
|
Crohn Disease | 1 | 2011 | 2304 | 0.040 |
Why?
|
Diagnostic Errors | 2 | 2018 | 1257 | 0.040 |
Why?
|
Escherichia coli Proteins | 1 | 2005 | 1050 | 0.040 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2021 | 548 | 0.040 |
Why?
|
Disease Progression | 2 | 2023 | 13286 | 0.040 |
Why?
|
Perinatal Care | 1 | 2020 | 227 | 0.040 |
Why?
|
Virulence Factors | 2 | 2016 | 509 | 0.040 |
Why?
|
Interferon Regulatory Factors | 1 | 2020 | 270 | 0.040 |
Why?
|
Protein Binding | 1 | 2010 | 9384 | 0.040 |
Why?
|
Symbiosis | 1 | 2020 | 287 | 0.040 |
Why?
|
Macaca mulatta | 3 | 2016 | 2377 | 0.040 |
Why?
|
Quality of Life | 1 | 2019 | 12802 | 0.040 |
Why?
|
Models, Statistical | 1 | 2012 | 5101 | 0.040 |
Why?
|
Desulfovibrio | 1 | 2017 | 7 | 0.040 |
Why?
|
Rhamnose | 1 | 2017 | 18 | 0.040 |
Why?
|
Salmonella typhimurium | 1 | 2019 | 351 | 0.040 |
Why?
|
Administration, Oral | 4 | 2007 | 3914 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2020 | 3296 | 0.040 |
Why?
|
Plasma | 1 | 2020 | 575 | 0.040 |
Why?
|
Virulence | 1 | 2021 | 1333 | 0.040 |
Why?
|
Carrier State | 1 | 2021 | 518 | 0.040 |
Why?
|
Rats, Transgenic | 1 | 2017 | 72 | 0.040 |
Why?
|
Influenza A virus | 1 | 2020 | 456 | 0.040 |
Why?
|
Nutrition Assessment | 1 | 2020 | 723 | 0.040 |
Why?
|
Lactose | 1 | 2017 | 95 | 0.040 |
Why?
|
HLA-B27 Antigen | 1 | 2017 | 76 | 0.040 |
Why?
|
Prevotella | 1 | 2017 | 79 | 0.040 |
Why?
|
Health Policy | 1 | 2009 | 2661 | 0.040 |
Why?
|
Rabbits | 3 | 2012 | 4894 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2019 | 15160 | 0.040 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7658 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2021 | 783 | 0.040 |
Why?
|
Vaccines | 1 | 2005 | 823 | 0.040 |
Why?
|
Toll-Like Receptor 2 | 2 | 2011 | 354 | 0.040 |
Why?
|
Autonomic Nervous System | 1 | 2021 | 672 | 0.040 |
Why?
|
Cost-Benefit Analysis | 1 | 2009 | 5388 | 0.040 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2002 | 685 | 0.040 |
Why?
|
SOX9 Transcription Factor | 1 | 2017 | 146 | 0.040 |
Why?
|
Avitaminosis | 1 | 2016 | 34 | 0.040 |
Why?
|
Epithelium | 1 | 2021 | 1679 | 0.030 |
Why?
|
Absorption | 2 | 2007 | 248 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 195 | 0.030 |
Why?
|
Biological Transport | 3 | 2007 | 2120 | 0.030 |
Why?
|
Diet Surveys | 1 | 2020 | 1173 | 0.030 |
Why?
|
Phospholipids | 1 | 2019 | 784 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2022 | 1813 | 0.030 |
Why?
|
Acute-Phase Proteins | 1 | 2017 | 262 | 0.030 |
Why?
|
Genetic Markers | 2 | 2012 | 2634 | 0.030 |
Why?
|
Vasculitis | 1 | 2019 | 519 | 0.030 |
Why?
|
Infant Formula | 1 | 2017 | 199 | 0.030 |
Why?
|
Family | 1 | 2006 | 3147 | 0.030 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2017 | 300 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9445 | 0.030 |
Why?
|
Dogs | 1 | 2019 | 3912 | 0.030 |
Why?
|
Family Health | 2 | 2012 | 1281 | 0.030 |
Why?
|
Fetal Development | 1 | 2020 | 767 | 0.030 |
Why?
|
Americas | 1 | 2014 | 111 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 4153 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2013 | 7914 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4751 | 0.030 |
Why?
|
Enteral Nutrition | 1 | 2020 | 767 | 0.030 |
Why?
|
Indomethacin | 1 | 2014 | 332 | 0.030 |
Why?
|
Bacteriophages | 1 | 2017 | 356 | 0.030 |
Why?
|
Medical Records | 1 | 2019 | 1413 | 0.030 |
Why?
|
Stem Cell Niche | 1 | 2017 | 346 | 0.030 |
Why?
|
Antigens, CD | 2 | 2017 | 4026 | 0.030 |
Why?
|
Risk Assessment | 3 | 2012 | 23336 | 0.030 |
Why?
|
Mice, Inbred A | 1 | 2013 | 248 | 0.030 |
Why?
|
Colitis, Microscopic | 1 | 2014 | 77 | 0.030 |
Why?
|
HeLa Cells | 1 | 2019 | 3130 | 0.030 |
Why?
|
Bread | 1 | 2012 | 23 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2018 | 810 | 0.030 |
Why?
|
Congo Red | 1 | 2012 | 46 | 0.030 |
Why?
|
Flour | 1 | 2012 | 19 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2014 | 3505 | 0.030 |
Why?
|
DNA | 1 | 2007 | 7294 | 0.030 |
Why?
|
Movement | 1 | 2019 | 1471 | 0.030 |
Why?
|
Shigella | 1 | 2013 | 74 | 0.030 |
Why?
|
Area Under Curve | 2 | 2007 | 1655 | 0.030 |
Why?
|
Esophagus | 1 | 2018 | 1019 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2020 | 15520 | 0.030 |
Why?
|
Body Mass Index | 1 | 2010 | 12721 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4933 | 0.030 |
Why?
|
Drug Interactions | 2 | 2007 | 1460 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2513 | 0.030 |
Why?
|
Sucrase-Isomaltase Complex | 1 | 2011 | 13 | 0.030 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2016 | 365 | 0.030 |
Why?
|
Cesarean Section | 1 | 2020 | 1365 | 0.030 |
Why?
|
Reference Values | 2 | 2012 | 4982 | 0.030 |
Why?
|
Norway | 1 | 2012 | 448 | 0.030 |
Why?
|
Spain | 1 | 2012 | 465 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12244 | 0.020 |
Why?
|
Antigen-Antibody Complex | 1 | 2013 | 517 | 0.020 |
Why?
|
Sodium-Glucose Transporter 1 | 1 | 2011 | 112 | 0.020 |
Why?
|
Integrin alpha Chains | 1 | 2011 | 97 | 0.020 |
Why?
|
Plasmids | 1 | 2016 | 2308 | 0.020 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2020 | 1444 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1978 | 0.020 |
Why?
|
Complement Activation | 1 | 2013 | 453 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2017 | 1970 | 0.020 |
Why?
|
Risk | 2 | 2014 | 9688 | 0.020 |
Why?
|
Schools | 1 | 2019 | 1433 | 0.020 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 1061 | 0.020 |
Why?
|
Germany | 1 | 2012 | 862 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2003 | 4459 | 0.020 |
Why?
|
Child Health Services | 1 | 2016 | 667 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2020 | 2073 | 0.020 |
Why?
|
Unnecessary Procedures | 1 | 2014 | 432 | 0.020 |
Why?
|
DNA, Viral | 1 | 2017 | 2227 | 0.020 |
Why?
|
Trans-Activators | 1 | 2020 | 2926 | 0.020 |
Why?
|
Ataxia | 1 | 2012 | 304 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2011 | 644 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2012 | 551 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2013 | 705 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1799 | 0.020 |
Why?
|
Proteomics | 1 | 2021 | 3638 | 0.020 |
Why?
|
Collagen Type I | 1 | 2011 | 592 | 0.020 |
Why?
|
Gestational Age | 1 | 2017 | 3493 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4216 | 0.020 |
Why?
|
History, 21st Century | 1 | 2014 | 1534 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 2891 | 0.020 |
Why?
|
Life Style | 1 | 2019 | 3835 | 0.020 |
Why?
|
Inulin | 1 | 2007 | 84 | 0.020 |
Why?
|
Linear Models | 1 | 2018 | 5953 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4386 | 0.020 |
Why?
|
Reperfusion Injury | 1 | 2014 | 1026 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2012 | 1213 | 0.020 |
Why?
|
Immunoglobulin E | 1 | 2013 | 1463 | 0.020 |
Why?
|
Macrophages, Peritoneal | 1 | 2008 | 251 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4554 | 0.020 |
Why?
|
Neoplasms | 2 | 2019 | 21696 | 0.020 |
Why?
|
Receptors, Interleukin | 1 | 2008 | 245 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2012 | 1997 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3589 | 0.020 |
Why?
|
Biomedical Research | 2 | 2013 | 3309 | 0.020 |
Why?
|
Trachea | 1 | 2013 | 1076 | 0.020 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2007 | 281 | 0.020 |
Why?
|
HLA-D Antigens | 1 | 2006 | 134 | 0.020 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2008 | 315 | 0.020 |
Why?
|
History, 20th Century | 1 | 2014 | 2740 | 0.020 |
Why?
|
Agglutination Tests | 1 | 2005 | 41 | 0.020 |
Why?
|
Indoles | 1 | 2014 | 1839 | 0.020 |
Why?
|
Developing Countries | 2 | 2013 | 2815 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2012 | 2560 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2017 | 3771 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2760 | 0.020 |
Why?
|
Lymphocyte Activation | 2 | 2010 | 5524 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2008 | 880 | 0.020 |
Why?
|
Fermentation | 1 | 2005 | 144 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2010 | 1227 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4208 | 0.020 |
Why?
|
Paris | 1 | 2004 | 42 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5867 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 11525 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 3658 | 0.020 |
Why?
|
Drug Compounding | 1 | 2005 | 242 | 0.020 |
Why?
|
Hydrolysis | 1 | 2005 | 682 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3595 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3611 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2282 | 0.020 |
Why?
|
Muscles | 1 | 2009 | 1614 | 0.010 |
Why?
|
Hygiene | 1 | 2004 | 97 | 0.010 |
Why?
|
Cell Separation | 1 | 2010 | 1751 | 0.010 |
Why?
|
K562 Cells | 1 | 2005 | 635 | 0.010 |
Why?
|
Clostridium tetani | 1 | 2003 | 5 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2014 | 1956 | 0.010 |
Why?
|
Administration, Rectal | 1 | 2003 | 73 | 0.010 |
Why?
|
Rhodamine 123 | 1 | 2003 | 38 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2011 | 1741 | 0.010 |
Why?
|
Colon | 1 | 2011 | 1772 | 0.010 |
Why?
|
Tetanus Toxin | 1 | 2003 | 49 | 0.010 |
Why?
|
Tetanus | 1 | 2003 | 53 | 0.010 |
Why?
|
Gene Silencing | 1 | 2010 | 1539 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2011 | 6313 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2012 | 4185 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9312 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2002 | 69 | 0.010 |
Why?
|
Biological Transport, Active | 1 | 2003 | 349 | 0.010 |
Why?
|
New York City | 1 | 2004 | 710 | 0.010 |
Why?
|
Cricetinae | 1 | 2006 | 2475 | 0.010 |
Why?
|
Polyethylene Glycols | 1 | 2007 | 1182 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2012 | 6036 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2005 | 2327 | 0.010 |
Why?
|
Ovalbumin | 1 | 2003 | 719 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5749 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10259 | 0.010 |
Why?
|
Molecular Weight | 1 | 2003 | 2255 | 0.010 |
Why?
|
Cell Membrane | 1 | 2010 | 3749 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8340 | 0.010 |
Why?
|
Homozygote | 1 | 2004 | 1787 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2011 | 3476 | 0.010 |
Why?
|
Capillaries | 1 | 2003 | 773 | 0.010 |
Why?
|
NF-kappa B | 1 | 2008 | 2499 | 0.010 |
Why?
|
Probability | 1 | 2005 | 2506 | 0.010 |
Why?
|
Odds Ratio | 1 | 2012 | 9849 | 0.010 |
Why?
|
Mitosis | 1 | 2004 | 1208 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2010 | 5974 | 0.010 |
Why?
|
Methotrexate | 1 | 2005 | 1728 | 0.010 |
Why?
|
Developed Countries | 1 | 2002 | 437 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2004 | 1375 | 0.010 |
Why?
|
Immunization | 1 | 2003 | 1256 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2002 | 1472 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11366 | 0.010 |
Why?
|
Paclitaxel | 1 | 2005 | 1708 | 0.010 |
Why?
|
Actins | 1 | 2005 | 2121 | 0.010 |
Why?
|
Epilepsy | 1 | 2012 | 3310 | 0.010 |
Why?
|
Apoptosis | 1 | 2012 | 9724 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 2009 | 3057 | 0.010 |
Why?
|
Research | 1 | 2004 | 1999 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2003 | 1917 | 0.010 |
Why?
|
Lung | 1 | 2013 | 9857 | 0.010 |
Why?
|
Primary Prevention | 1 | 2002 | 1167 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2004 | 2897 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 14561 | 0.010 |
Why?
|
Health Promotion | 1 | 2004 | 2205 | 0.010 |
Why?
|
Calcium | 1 | 2002 | 5755 | 0.010 |
Why?
|